Jm. Anaya et al., CLINICOPATHOLOGICAL FACTORS RELATING MALIGNANT-LYMPHOMA WITH SJOGRENS-SYNDROME, Seminars in arthritis and rheumatism, 25(5), 1996, pp. 337-346
This study was undertaken to summarize the current status of the clini
copathologic factors related to non-Hodgkin's lymphoma (NHL) developme
nt in patients with Sjogren's syndrome (SS). Through a MEDLINE search,
pertinent articles on SS, monoclonality, and NHL were found and revie
wed. Malignant lymphoma description was based on the International Lym
phoma Study Group classification. Patients with SS are known to have a
n increased risk for developing B-cell NHL (B-NHL). However, such a co
mplication occurs in less than 10% of patients, being reported mainly
in those with primary SS. Extranodal low-grade B-NHL are observed most
frequently. Persistent enlargement of parotid glands, adenopathy, mon
oclonal gammopathy, and crossreactive idiotypes are all signs suggesti
ng possible lymphoma evolution. Although monoclonality does not mean m
alignancy unequivocally, it is considered to be a precursor for NHL de
velopment in SS. Factors implicated into lymphomagenesis in SS include
dysregulation in the mechanisms leading to apoptosis, hyperstimulatio
n of B-1 cells, and an infectious agent. Polyclonal lymphoproliferatio
n characterizing SS might in some instances transform into monoclonal,
and then to malignancy. Further studies on the mechanism whereby NHL
develops in SS are warranted. (C) 1996 by W.B. Saunders Campany